Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | ACHE | P22303 | 2/20 | 0.31 |
| ▸ | BPTF | Q12830 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9822175 | 0.97 | PKM (0.36) | KDM1ALMNAPKMMEN1KMT2A | |
| SCHEMBL9822165 | 0.88 | KDM4E (0.32) | KDM1ALMNAPKMKDM4EKDM5B | |
| SCHEMBL9822221 | 0.85 | PKM (0.34) | LMNAPKMKDM4EMEN1KMT2A | |
| SCHEMBL3582081 | 0.83 | PKM (0.48) | KDM1ALMNAPKMKDM4EMEN1 | |
| SCHEMBL9822417 | 0.83 | LMNA (0.35) | KDM1ALMNAPKMKDM4EKDM5B | |
| SCHEMBL9822255 | 0.81 | LMNA (0.33) | KDM1ALMNAPKMNPSR1MEN1 | |
| SCHEMBL9822171 | 0.80 | PKM (0.35) | KDM1ALMNAPKMKDM4ENPSR1 | |
| SCHEMBL9822104 | 0.78 | PKM (0.36) | LMNAPKM | |
| SCHEMBL10408138 | 0.73 | PKM (0.46) | LMNAPKMKDM4EMEN1KMT2A | |
| SCHEMBL9822215 | 0.73 | LMNA (0.37) | KDM1ALMNAPKMKDM4EKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4987129-A | BACTERICIDES | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4958019-A | Intermediates for synthesis of cephalosporin compounds | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| US-4956462-A | Bactericides, ANTIBIOTICS, CEPHALOSPORINS | SANKEI PHARMACEUTICAL CO., LTD. (JP) | 1990-09-11 | — | — | US | disclosed |
| EP-0302633-A2 | Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same | SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) | 1989-02-08 | — | — | EP | disclosed |